AMENDMENT No. 6License Agreement • March 20th, 2014 • Astrazeneca PLC • Pharmaceutical preparations
WHEREAS, there existed differences between Shionogi and AstraZeneca on the interpretation of the definition of NET SALES under the License Agreement, and on 20 July 2012, Shionogi started ICC arbitration proceedings against AstraZeneca relating to such differences (the “Arbitration Proceedings”);
DEED OF INDEMNITYDeed of Indemnity • March 20th, 2014 • Astrazeneca PLC • Pharmaceutical preparations • England and Wales
